Uni-Gold™ HIV Complete

Captia™ SARS-CoV-2 IgG ELISA



A qualitative, 96 well microplate ELISA assay, detecting IgG antibodies to S1 & S2 spike antigens of the SARS-CoV-2 virus in serum & plasma.  Manufactured with recombinant antigens, crucial for maximum sensitivity and specificity.


  • Excellent performance: 95.1%* Sensitivity / 98.2% Specificity
  • Fast assay time (30:30:15)
  • All room temperature incubation rather than 37°C
  • IgG detection – Interim Guidance from the CDC on COVID-19 antibody testing states, “Currently there is no identified advantage whether the assay tests for IgG, IgM and IgG, or total antibody.” **
  • Easily adaptable to multiple platforms – applications available
  • Consistent and reliable, the Captia™ brand has a 30 year history of excellence


* For samples ≥14 days from symptom onset.

**Interim Guidelines for COVID-19 Antibody Testing, Rev August 1, 2020, Centre for Disease Control


Currently listed under FDA’s Notification Policy for COVID-19 serology tests which permits distribution of this test in the US, pending review of the EUA.

New Resolution Analytical Column

Premier Resolution Mobile Phase 2, 940mL

Premier Resolution Mobile Phase 1, 940mL

Uni-Gold™ HIV

Uni-Gold™ HIV Complete

BUP One Step Buprenorphine Test Device

Tri-stat Reagent Kit (90)

Tri-stat Reagent Kit (60)

Tri-stat Reagent Kit (30)

NCS One Step Buprenorphine Test Device

Tri-stat 2 Analyzer

Introducing the Tri-stat 2, designed and developed taking into account years of field experience with the Tri-stat 1. The Tri-stat 2 offers accurate and precise HbA1c results within minutes, using boronate affinity technology and a two phase optical system. The Tri-stat 2 is an ideal solution for small laboratories with a low volume throughput.

Dilution Blocks/Racks

22 dilution blocks: 100 pieces

Caps for vials

1000 pieces

Reagent vials


ImmuLisa™ Enhanced ANA Screen ELISA

ImmuLisa Serum Diluent

ImmuGlo Immunofluorescence Reagent Set

ImmuGlo Paraneoplastic/Pemphigus Positive Control